Isavuconazonium Sulfate Patent Expiration
Isavuconazonium Sulfate was first introduced by Astellas Pharma Us Inc
Isavuconazonium Sulfate Patents
Given below is the list of patents protecting Isavuconazonium Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cresemba |
US10206879 (Pediatric) | Active ingredient containing stabilised solid forms and method for the production thereof | Mar 14, 2028 | Astellas |
| Cresemba |
US10603280 (Pediatric) | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof | Mar 14, 2028 | Astellas |
| Cresemba | US10206879 | Active ingredient containing stabilised solid forms and method for the production thereof | Sep 14, 2027 | Astellas |
| Cresemba | US10603280 | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof | Sep 14, 2027 | Astellas |
| Cresemba |
US6812238 (Pediatric) | N-substituted carbamoyloxyalkyl-azolium derivatives | Apr 30, 2026 | Astellas |
| Cresemba | US10812238 | Configurable reference signals | Oct 31, 2025 | Astellas |
| Cresemba | US6812238 | N-substituted carbamoyloxyalkyl-azolium derivatives | Oct 31, 2025 | Astellas |
| Cresemba | US7459561 | N-substituted carbamoyloxyalkyl-azolium derivatives |
Oct 31, 2020
(Expired) | Astellas |
Isavuconazonium Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List